Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency. [PDF]
J Virol, 2021 Mannemuddhu SS +5 more
europepmc +1 more source
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>. [PDF]
ACS Infect Dis, 2023 Jeffreys LN +20 more
europepmc +1 more source
Identification of the New In Vivo Metabolites of Ilaprazole in Rat Plasma after Oral Administration by LC-MS: In Silico Prediction of the H+/K+-ATPase Inhibitor. [PDF]
Molecules, 2021 Zhang G, Guo K, Wang P, Shan Y, Ma C.
europepmc +1 more source
Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients. [PDF]
Clin Transl Sci, 2021 Zhao YC +9 more
europepmc +1 more source
Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use. [PDF]
Drug Des Devel Ther, 2020 Chen F, He X, Fang B, Wang S.
europepmc +1 more source
The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori. [PDF]
Medicine (Baltimore), 2020 Lee SW +7 more
europepmc +1 more source
Comparative analysis of the effect of PO administered acid suppressants on gastric pH in healthy cats. [PDF]
J Vet Intern Med, 2020 Ryan P +7 more
europepmc +1 more source
A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations. [PDF]
Br J Clin Pharmacol, 2020 Blanco Dorado S +16 more
europepmc +1 more source
Proton pump inhibitors and risk for gastric cancer: Is it real? [PDF]
Turk J Gastroenterol, 2019 Akriviadis E, Liava C.
europepmc +1 more source
Metabolomics study of COVID-19 patients in four different clinical stages. [PDF]
Sci Rep, 2022 Valdés A +5 more
europepmc +1 more source